Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DF1

Chi3l1 bound by antibody C59

8DF1 の概要
エントリーDOI10.2210/pdb8df1/pdb
分子名称Chitinase-3-like protein 1, C59 Fab Heavy chain, C59 Fab Light chain, ... (6 entities in total)
機能のキーワードchi3l1, fab, immunotherapeutic, immune system
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数18
化学式量合計524620.76
構造登録者
Wrapp, D.,McLellan, J.S. (登録日: 2022-06-21, 公開日: 2023-03-01, 最終更新日: 2024-10-09)
主引用文献Li, L.,Wen, Y.,Wrapp, D.,Jeong, J.,Zhao, P.,Xiong, W.,Atkins, C.L.,Shan, Z.,Hui, D.,McLellan, J.S.,Zhang, N.,Ju, C.,An, Z.
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice.
Antib Ther, 6:1-12, 2023
Cited by
PubMed Abstract: Acetaminophen (APAP) overdose is a leading cause of acute liver injury in the USA. The chitinase 3-like-1 (Chi3l1) protein contributes to APAP-induced liver injury (AILI) by promoting hepatic platelet recruitment. Here, we report the development of a Chi3l1-targeting antibody as a potential therapy for AILI. By immunizing a rabbit successively with the human and mouse Chi3l1 proteins, we isolated cross-reactive monoclonal antibodies (mAbs) from single memory B cells. One of the human and mouse Chi3l1 cross-reactive mAbs was humanized and characterized in both and biophysical and biological assays. X-ray crystallographic analysis of the lead antibody C59 in complex with the human Chi3l1 protein revealed that the kappa light contributes to majority of the antibody-antigen interaction; and that C59 binds to the 4α-5β loop and 4α-helix of Chi3l1, which is a functional epitope and hotspot for the development of Chi3l1 blocking antibodies. We humanized the C59 antibody by complementarity-determining region grafting and kappa chain framework region reverse mutations. The humanized C59 antibody exhibited similar efficacy as the parental rabbit antibody C59 in attenuating AILI . Our findings validate Chi3l1 as a potential drug target for AILI and provide proof of concept of developing Chi3l1 blocking antibody as a therapy for the treatment of AILI.
PubMed: 36683763
DOI: 10.1093/abt/tbac027
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.3 Å)
構造検証レポート
Validation report summary of 8df1
検証レポート(詳細版)ダウンロードをダウンロード

231356

件を2025-02-12に公開中

PDB statisticsPDBj update infoContact PDBjnumon